Gene Targeting and Expression Modulation by Peptide Nucleic Acids (PNA)

Current Pharmaceutical Design

Volumn 16, Issue 28, 2010, Pages 3118-3123

  Nielsen, Peter E ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antisense; Delivery; Gene targeting; PNA; Transcription

Indexed keywords

CELL PENETRATING PEPTIDE; DOUBLE STRANDED DNA; MICRORNA; OLIGOMER; PEPTIDE NUCLEIC ACID; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTISENSE THERAPY; ARTICLE; CELL COMPARTMENTALIZATION; CHEMICAL STRUCTURE; DNA RNA HYBRIDIZATION; DNA STRUCTURE; DNA TRANSCRIPTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EXON; GENE EXPRESSION; GENE TARGETING; GENE TECHNOLOGY; HUMAN; HYBRIDIZATION; IMMUNOMODULATION; INTRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RNA INTERFERENCE; RNA SPLICING; RNA TRANSCRIPTION; STAPHYLOCOCCUS AUREUS; TARGETED GENE REPAIR; TATA BOX; VIRUS GENOME;

ANIMALS; ANTI-INFECTIVE AGENTS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE EXPRESSION REGULATION; GENE TARGETING; HUMANS; MODELS, GENETIC; PEPTIDE NUCLEIC ACIDS; RNA, ANTISENSE;

EID: 78649822317     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210793292546     Document Type: Article

References (76)

1. Nielsen PE, Egholm M, Berg RH, Buchardt O. Sequence-selective recognition of DNA by Strand displacement with a thyminesubstituted polyamide. Science 1991; 254: 1497-500.
2. Egholm M, Buchardt O, Christensen L, et al. PNA hybridizes to complementary oligonucleotides obeying the watson-crick hydrogen-bonding rules. Nature 1993; 365: 566-8.
3. Nielsen PE Peptide nucleic acid. A molecule with two identities. Accounts Chem Res 1999; 32: 624-30.
4. Brown SC, Thomson SA, Veal JM, Davis DG. NMR Solution structure of a peptide nucleic acid complexed with RNA. Science 1994; 265: 777.
5. Rasmussen H, Kastrup JS, Nielsen JN, Nielsen JM, Nielsen PE. Crystal structure of a peptide nucleic acid (PNA) duplex at 1.7 Å resolution. Nat Struct Biol 1997; 4: 98-101.
6. Eriksson M, Nielsen PE. PNA-nucleic acid complexes. Structure, stability and dynamics. Quart Rev Biophys 1996; 29: 369-94
7. Nielsen PE. Modulating gene function with peptide nucleic acids (PNA). In: Crooke ST, Ed. antisense drug technology. Taylor francis group, CRC Press 2008; Chapter 18.
8. Nielsen E. RNA targeting using peptide nucleic acid. In: Erdmann V, Brosius J, Barciszewski J, Eds. RNA towards medicine; Springer 2006; Vol. 173.
9. Nielsen PE. Antisense peptide nucleic acids. Curr Opinion Mole Therapeut 2000; 2: 282-7.
10. Sazani P, Kang SH, Maier MA, et al. Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Res 2001; 29: 3965-74.
11. Shiraishi T, Pankratova S, Nielsen PE. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. Chemi Biol 2005; 12: 923-9
12. Abes S, Moulton H, Turner J, et al. Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides. Biochem Soc Transact 2007; 35: 53-5
13. Sazani P, Kole R. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J Clin Invest 2003; 112: 481-6
14. Kole R, Vacek M, Williams T. Modification of alternative splicing by antisense therapeutics. Oligonucleotides 2004; 14: 65-74
15. Ivanova GD, Arzumanov A, Abes R, et al. Improved cellpenetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle. Nucleic Acids Res 2008; 36: 6418-28.
16. Yin H, Lu Q, Wood M. Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. Mol Therapy 2008; 16: 38-45
17. Fletcher S, Honeyman K, Fall AM, Harding PL, Johnsen RD, Wilton SD. Dystrophin expression in the Mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. J Gene Med 2006; 8: 207-16
18. Yokota T, Takeda S, Lu QL, Partridge TA, Nakamura A, Hoffman EP. A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground. Arch Neurol 2009; 66: 32-8
19. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-14
20. Fabani MM. and Gait MJ. miR-122 targeting with LNA/2'-Omethyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA 2008; 14: 336-46.
21. Oh SY, Ju Y, Park H. A Highly Effective and Long-Lasting Inhibition of MiRNAs With PNA-Based Antisense Oligonucleotides. Molecules Cells 2009; 28: 341-5.
22. Bentin T, Nielsen PE. Superior duplex DNA strand invasion by acridine conjugated peptide nucleic acids. J Am Chem Soc 2003; 125: 6378-9.
23. Bentin T, Hansen GI, Nielsen PE. structural diversity of targetspecific homopyrimidine peptide nucleic acid-dsDNA complexes. Nucleic Acids Res 2006; 34: 5790-9.
24. Krupnik OV, Fadeeva NV, Kvitko NP, Shepelev VA, Nielsen PE, Lazurkin YS. Stability and transformations of bis-PNA/DNA triplex structural isomers. J Biomol Struct Dynam 2004; 21: 503-12.
25. Demidov VV, Yavnilovich MV, Belotserkovskii BP, Frank- Kamenetskii MD, Nielsen PE. Kinetics and mechanism of polyamide (Peptide) nucleic acid binding to duplex DNA. Proc Natl Acad Sci USA 1995; 92: 2637-41.
26. Hansen ME, Bentin T, Nielsen PE. High-affinity triplex targeting of double stranded DNA using chemically modified peptide nucleic acid oligomers. Nucleic Acids Res 2009; 37: 4498-507.
27. Egholm M, Christensen L, Dueholm KL, Buchardt O, Coull J, Nielsen PE. Efficient PH-independent sequence-specific DNA binding by pseudoisocytosine-containing bis-PNA. Nucleic Acids Res 1995; 23: 217-22.
28. Lohse J, Dahl O, Nielsen PE. Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double-stranded DNA. Proc Natl Acad Sci USA 1999; 96: 11804-8.
29. Izvolsky KI, Demidov VV, Nielsen PE, Frank-Kamenetskii MD. Sequence-specific protection of duplex DNA against restriction and methylation enzymes by pseudocomplementary PNAs. Biochemistry 2000; 39: 10908-13.
30. Kim KH, Nielsen PE, Glazer PM. Site-directed gene mutation at mixed sequence targets by psoralen-conjugated pseudo-complementary peptide nucleic acids, Nucleic Acids Res 2007; 45: 314-23.
31. Katada H, Komiyama M. Artificial restriction DNA cutters as new tools for gene manipulation, ChemBioChem 2009; 10: 1279-88.
32. Ishizuka T, Yoshida J, Yamamoto Y, et al. Chiral introduction of positive charges to PNA for double-duplex invasion to versatile sequences, Nucleic Acids Res 2008; 36: 1464-71.
33. Nielsen PE, Christensen L. Strand displacement binding of a duplex-forming homopurine PNA to a homopyrimidine duplex DNA target. J Am Chem Soc 1996; 118: 2287-8.
34. Rapireddy S, He G, Roy S, Armitage BA, Ly DH. Strand invasion of mixed-sequence B-DNA by acridine-linked, gamma-peptide nucleic acid (gamma-PNA), J Am Chem Soc 2007; 129: 15596-600.
35. Flanagan WM, Wolf JJ, Olson P, et al. A cytosine analog that confers enhanced potency to antisense oligonucleotides. Proc Natl Acad Sci USA 1999; 96: 3513-8.
36. Chenna V, Rapireddy S, Sahu B, Ausin C, Pedroso E, Ly DH. A simple cytosine to G-clamp nucleobase substitution enables chiral G-PNAs to invade mixed-sequence double-helical B-form DNA, ChemBioChem 2008; 9: 2388-91.
37. Roy S, Tanious FA, Wilson WD, Ly DH, Armitage B. A highaffinity homologous peptide nucleic acid probes for targeting a quadruplex-forming sequence from a MYC promoter element, Biochemistry 2007; 46: 10433-43.
38. Nielsen PE, Egholm M, Buchardt O. Sequence-specific transcription arrest by peptide nucleic acid bound to the DNA template strand. Gene 1994; 149: 139-45.
39. Hanvey JC, Peffer NJ, Bisi JE, et al. Antisense and antigen properties of peptide nucleic acids. Science 1992; 258: 1481-5.
40. Møllegaard NE, Buchardt O, Egholm M, Nielsen PE. Peptide nucleic acid-DNA strand displacement loops as artificial transcription promoters. Proc Natl Acad Sci USA 1994; 91: 3892-5.
41. Chin JY, Kuan JY, Lonkar PS, et al. Correction of a splice-site mutation in the beta-globin gene stimulated by triplex-forming peptide nucleic acids, Proc Natl Acad Sci USA 2008; 105: 13514-9.
42. Janowski BA, Kaihatsu K, Huffman KE, et al. Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids. Nat Chem Biol 2005; 1: 210-5.
43. Milne L, Xu Y, Perrin DM, Sigman DS. An approach to genespecific transcription inhibition using oligonucleotides complementary to the template strand of the open complex. Proc Natl Acad Sci USA 2000; 97: 3136-41
44. Larsen HJ, Nielsen PE. Transcription-mediated binding of peptide nucleic acid (PNA) to double-stranded DNA: sequence-specific suicide transcription. Nucleic Acids Res 1996; 24: 458-63.
45. Boffa LC, Cutrona G, Cilli M, et al. Inhibition of burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated C-Myc. Cancer Gene Therapy 2007; 14: 220-6.
46. Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 2009; 61: 850-62.
47. Sazani P, Gemignani F, Kang S.-H, et al. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat Biotechnol 2002; 20: 1228-33.
48. Lebleu B, Moulton HM, Abes R, et al. Cell penetrating peptide conjugates of steric block oligonucleotides. Adv Drug Deliv Rev 2008; 60: 517-29.
49. El-Andaloussi S, Johansson HJ, Holm T, Langel Ü. A novel cellpenetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. Mol Therapy 2007; 15: 1820-6.
50. Bendifallah N, Rasmussen FW, Zachar V, Ebbesen P, Nielsen PE, Koppelhus U. Evaluation of cell-penetrating peptides (CPPs) As vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconjug Chem 2006; 17: 750-8.
51. Koppelhus U, Awasthi SK, Zachar V, Holst HU, Ebbesen P, Nielsen PE. Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Develop 2002; 12: 51-63.
52. Richard JP, Melikov K, Vives E, et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003; 278: 585-90.
53. Shiraishi T, Nielsen PE. Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates. FEBS Lett 2006; 580: 1451-6.
54. Hu J. and Corey DR. Inhibiting gene expression with peptide nucleic acid (PNA)-peptide conjugates that target chromosomal DNA. Biochemistry 2007; 46: 7581-9.
55. Koppelhus U, Shiraishi T, Zachar V, Pankratova S, Nielsen PE. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain. Bioconjugate Chem 2008; 19: 1526-34.
56. Hamilton SE, Simmons CG, Kathiriya IS, Corey DR. Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem Biol 1999; 6: 343-51.
57. Shiraishi T, Hamzavi R, Nielsen PE. Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells. Nucleic Acids Res 2008; 36: 4424-32.
58. Hamzavi R, Dolle F, Tavitian B, Dahl O, Nielsen PE. Modulation of the pharmacokinetic properties of PNA: Preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers. Bioconjug Chem 2003; 14: 941-54.
59. McMahon BM, Mays D, Lipsky J, Stewart JA, Fauq A, Richelson E. Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. Antisense Nucleic Acid Drug Development 2002; 12: 65-70.
60. Tan XX, Actor JK, Chen Y. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrob Agents Chemother 2005; 49: 3203-7.
61. Chaubey B, Tripathi S, Pandey VN. Single acute-dose and repeatdoses toxicity of anti-HIV-1 PNA(TAR)-penetratin conjugate after intraperitoneal administration to mice. Oligonucleotides 2008; 18: 9-20.
62. Ganguly S, Chaubey B, Tripathi S, et al. Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element. Oligonucleotides 2008; 18: 277-86.
63. Upadhyay A, Ponzio NM, Pandey VN. Immunological response to peptide nucleic acid and its peptide conjugate targeted to transactivation response (TAR) region of HIV-1 RNA genome. Oligonucleotides 2008; 18: 329-36.
64. Good L, Nielsen PE. Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proc Natl Acad Sci USA 1998; 95: 2073-6.
65. Good L, Nielsen PE. Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat Biotechnol 1998; 16: 355-8.
66. Good L, Awasthi SK, Dryselius R, Larsson O, Nielsen PE. Bactericidal antisense effects of peptide-PNA conjugates. Nat Biotechnol 2001; 19: 360-4.
67. Nekhotiaeva N, Awasthi SK, Nielsen PE, Good L. Inhibition of staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol Therapy 2004; 10: 652-9.
68. Pandey VN, Upadhyay A, Chaubey B. Prospects for antisense peptide nucleic acid (PNA) therapies for HIV. Expert Opin Biol Ther 2009; 9: 975-89.
69. Tripathi S, Chaubey B, Ganguly S, Harris D, Casale RA, Pandey VN. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides. Nucleic Acids Res 2005; 33: 4345-56.
70. Chaubey B, Tripathi S, Ganguly S, Harris D, Casale RA, Pandey VN. A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties. Virology 2005; 331: 418-28.
71. Tripathi S, Chaubey B, Barton BE, Pandey VN. Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 Genome. Virology 2007; 363: 91-103.
72. Robaczewska M, Narayan R, Seigneres B, et al. Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA). J Hepatol 2005; 42: 180-7.
73. Yoo JS, Kim CM, Kim JH, Kim JY, Oh JW. Inhibition of japanese encephalitis virus replication by peptide nucleic acids targeting cisacting elements on the plus- and minus-strands of viral RNA. Antiviral Res 2009; 82: 122-33.
74. Gambari R. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers. Curr Pharm Des 2001; 7(17): 1839-62.
75. Pellestor F, Paulasova P, Hamamah S. Peptide nucleic acids (PNAs) as diagnostic devices for genetic and cytogenetic analysis. Curr Pharm Des 2008; 14(24): 2439-44.
76. Xodo LE, Cogoi S, Rapozzi V. Anti-gene strategies to downregulate gene expression in mammalian cells. Curr Pharm Des 2004; 10(7): 805-19